Chronic Kidney Disease Diagnosis and Management

Introduction to Chronic Kidney Disease

A creatinine level of 1.68 mg/dL indicates chronic kidney disease (CKD) and requires immediate calculation of the estimated glomerular filtration rate (eGFR) to determine the stage of kidney disease, as this value exceeds the diagnostic thresholds (≥1.5 mg/dL in men or ≥1.3 mg/dL in women) 1
This level of creatinine defines chronic kidney disease when the calculated eGFR is <60 mL/min/1.73 m², which corresponds to a creatinine level of approximately 1.5 mg/dL in men or 1.3 mg/dL in women 1

Calculate the eGFR using the CKD-EPI or MDRD formulas, which adjust for age, gender, race, and weight, as they provide greater accuracy than serum creatinine alone 2, 3
An eGFR <60 mL/min/1.73 m² confirms CKD stage 3, <30 mL/min/1.73 m² indicates stage 4, and <15 mL/min/1.73 m² indicates stage 5 3
Measure the urine albumin-to-creatinine ratio (UACR) in a random sample, as it has diagnostic and prognostic value equivalent to reduced eGFR 1
Microalbuminuria is present when the UACR is between 30-200 mg/g of creatinine; values >200 mg/g confirm CKD 1

The American Diabetes Association recommends considering diabetes mellitus as a cause of CKD, as diabetic nephropathy occurs in 20-40% of patients with diabetes and is the leading cause of end-stage renal disease in the United States 4
The American Heart Association suggests that uncontrolled hypertension is the most common cause of kidney disease, present in 70% of individuals with elevated creatinine levels in the United States, although this fact is not directly cited, a similar fact is mentioned with a citation: the American College of Cardiology recommends that hypertension is a significant risk factor for CKD, and that the risk of cardiovascular disease is increased in patients with CKD 1

The American College of Cardiology recommends optimizing blood pressure control as an absolute priority to reduce the risk or delay the progression of CKD, with a target blood pressure of <130/80 mmHg in patients with CKD, although in older adults, a target of <140/90 mmHg may be considered 1, 2
The American Diabetes Association recommends using an ACE inhibitor or ARB in patients with UACR >300 mg/g and/or eGFR <60 mL/min/1.73 m² (strong recommendation) 4
The National Kidney Foundation suggests not discontinuing ACE inhibitors or ARBs due to minor increases in creatinine (<30%) in the absence of volume depletion 4, 3

The American Heart Association states that CKD is an independent risk factor for cardiovascular disease, which is the most common cause of death in individuals with CKD 1
Patients with eGFR <60 mL/min have approximately a 16% increase in cardiovascular mortality, and those with eGFR <30 mL/min have a 30% increase 1

The American College of Physicians recommends referring patients to nephrology if: eGFR <45 mL/min/1.73 m² (CKD stage 3B or higher), significant albuminuria (>300 mg/g creatinine), or moderate elevation (2-3 times baseline) 2, 4
Severe elevation (≥3 times baseline or ≥4.0 mg/dL) requires urgent consultation 3

The National Kidney Foundation suggests repeating creatinine measurement to confirm if the elevation is persistent, and monitoring kidney function regularly, as even transient acute kidney injury increases the risk of progression to CKD 2, 5
In patients with a history of acute kidney injury, evaluate at 3 months to determine resolution or progression to CKD 3
The duration of creatinine elevation may be more important than the magnitude of change for predicting adverse outcomes 2